AURASENSE THERAPEUTICS, LLC

Basic Information

8045 Lamon Ave
SUITE 410
SKOKIE, IL, 60077-5317

http://www.aurasensetherapeutics.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 968721535
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 16


  1. Topically-delivered Mutation-specific Gene Targeting for Epidermolytic Ichthyosis

    Amount: $224,935.00

    DESCRIPTION (provided by applicant): AuraSense Therapeutics (AST), along with Northwestern University, is applying a recently developed technology using oligonucleotide-functionalized nanoparticles (c ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Topically-delivered Targeted Gene Suppression of Immune Activation in Psoriasis

    Amount: $149,941.00

    DESCRIPTION (provided by applicant): AuraSense Therapeutics (AST), along with Northwestern University, is applying a recently developed technology using oligonucleotide-functionalized nanoparticles (c ...

    STTR Phase I 2014 Department of Health and Human Services
  3. Genetically Programmable Spherical Nucleic Acids as Rapidly Adaptable Nanotherapeutics

    Amount: $986,621.00

    AuraSense Therapeutics is developing oligonucleotide-modified gold nanoparticles called Spherical Nucleic Acid (SNA) constructs, which are a powerful new way of regulating cellular gene expression. Au ...

    SBIR Phase II 2013 Defense Advanced Research Projects Agency Department of Defense
  4. Genetically Programmable Spherical Nucleic Acids as Rapidly Adaptable Nanotherapeutics

    Amount: $149,295.00

    AuraSense Therapeutics is developing oligonucleotide-modified gold nanoparticles called spherical nucleic acid (SNA) constructs, which are a powerful new way of regulating cellular gene expression. Au ...

    SBIR Phase I 2012 Defense Advanced Research Projects Agency Department of Defense

Agency Micro-sites

US Flag An Official Website of the United States Government